Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. - Wikidata - wikimedia - TriplyDB

Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications.

Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications.

http://www.wikidata.org/entity/Q36396727

about

Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications Evidence for classification of c.1852_1853AA>GC in MLH1 as a neutral variant for Lynch syndrome Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer.Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma Clinicopathological and genetic features of Chinese hereditary nonpolyposis colorectal cancer (HNPCC).Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes Hereditary ovarian cancer: not only BRCA 1 and 2 genes.Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome.Bayesian modeling for genetic anticipation in presence of mutational heterogeneity: a case study in Lynch syndrome.Lynch syndrome: barriers to and facilitators of screening and disease management Colorectal cancers with microsatellite instability display unique miRNA profiles.Anticipation in lynch syndrome: where we are where we go Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer.Genetic testing for Lynch syndrome: family communication and motivation Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing Hereditary cancer syndrome diagnosis: molecular genetic clues and cancer control.Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients.The molecular biology of gastrointestinal cancer: implications for diagnosis and therapy.Familial and genetic risk of transitional cell carcinoma of the urinary tract.Genetic predispositions to childhood leukemia.Hsa-miR-137, hsa-miR-520e and hsa-miR-590-3p perform crucial roles in Lynch syndrome.Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.Genetic risk and gynecologic cancers.Genetic variants in the cell cycle control pathways contribute to early onset colorectal cancer in Lynch syndrome.A comparison between Lynch syndrome and sporadic colorectal cancer survivors' satisfaction with their healthcare providers Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study.Hereditary ovarian and breast cancer: what have we learned?Haematuria in association with Lynch syndrome.Mismatch repair deficiency testing in clinical practice.Unstable DNA repair genes shaped by their own sequence modifying phenotypes.Synchronous rectal and gastric cancer in a fighter pilot: aeromedical concerns.Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer.Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.Prevalence and clinicopathologic/molecular characteristics of mismatch repair-deficient colorectal cancer in the under-50-year-old Japanese population.

P2860

Q24610838-5D7893EC-9807-42A3-B919-3C1FC133A0B6 Q33797266-4D73B8DE-CA60-4292-BFD4-59333E4ABB67 Q33862772-387FF3B8-6E31-4317-A257-7DA055BD740F Q33933576-D985F205-FA23-4D12-8921-578927C679CB Q34163849-15D0D68A-0566-4250-9F46-DBB3453A7875 Q34174654-33BCB901-3432-4BD2-8B24-E8B7C0281DB9 Q34243496-8F3225FA-87AD-4AB1-8A91-01D47EAA14E9 Q34480707-88DD9FD8-D96F-45DC-9682-89FFBC831679 Q34610509-0BDAB7BA-5840-4CDA-88D9-F18B78EE75B6 Q34977063-7703CCF2-5062-4F49-B1ED-F472C18F5BB1 Q35168638-6DE76396-0C15-4034-944A-95A61C0B8B70 Q35223852-C5324B17-BF6D-439F-BA11-FDB4EFA0E4D7 Q35233167-99A7ADBE-A408-4675-BA37-6471E5FD98C0 Q35269096-F85FECA2-3F73-4701-933B-6EB191EABC74 Q35560811-9B0091D8-B07D-47AF-9747-DB8C79DB06DD Q35799369-CF246C08-31A3-4B27-B947-626FB3A8E27D Q36094483-9302D616-201C-45B3-9198-FEF4209851E3 Q36315747-50BECFAF-BFFB-4E19-A119-834C14DF8F88 Q36422099-E37ABBCF-6080-45E7-9197-AA8902419784 Q36734614-69931735-66C8-4057-98B0-5E998B3FCCDF Q36768291-3E3E1D0D-E841-4484-9C17-15E295B583C0 Q36890349-72CDCB2E-BB4A-4EA1-A3EE-D2853EDB2178 Q36923700-D82F8457-E093-4653-9EF2-03533D7443DC Q36951321-EDCC8514-233E-4A49-A8CD-70223782C5B9 Q37073895-A6990E0E-1162-43C2-B6AF-51666EA62034 Q37206009-D6D917E0-99C3-40AB-8A65-A5905EA0A901 Q37221791-FA8EDAC9-D01D-4B63-95EB-A898A9DA9D13 Q37468316-AFD09289-6CBA-4C2C-9387-BB4F26683CEF Q37566958-97D2FE04-9FA0-46BC-B006-633400D0F489 Q37693398-0BD434D5-24E7-47F8-965F-781269C5B4F0 Q37712344-F54F4433-2A9F-4387-BEDA-0DD35B586DF0 Q38153188-E2DB3812-57DD-436E-8A55-7C1F54F0F0F3 Q38679590-C62D19C3-8C25-4AD9-8166-156858B70054 Q38741029-84BDBABE-BE75-4DC0-BD73-919C2569FD76 Q39818303-B86CFD8B-2C18-4453-9C93-E2F1CA52CE4F Q41894902-43FAD5E2-D3AC-4E6F-8335-7501B46A840C Q42175718-ED3308AD-92DC-4C43-BCCF-5DEF02492C17 Q42836059-9AD445EA-FF5B-4FDD-B444-D9D8C1193933 Q48282014-32C7501E-3193-4050-89E5-58FAA1DD994B

P2860

Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications.

http://www.wikidata.org/entity/Q36396727

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Phenotypic and genotypic heter ...... e and management implications.

@ast

Phenotypic and genotypic heter ...... e and management implications.

@en

type

label

Phenotypic and genotypic heter ...... e and management implications.

@ast

Phenotypic and genotypic heter ...... e and management implications.

@en

prefLabel

Phenotypic and genotypic heter ...... e and management implications.

@ast

Phenotypic and genotypic heter ...... e and management implications.

@en

P1433

Q36396727-2E52D742-BD0B-44F8-A92A-8AA2D24D95F4

P1476

Q36396727-AE8E9A1F-89E5-4CF2-B3F3-E4025B088B98

P2093

Q36396727-103F5B19-47D8-4C5F-B905-481C8F84C6C9

Q36396727-1998C618-F621-41BF-83DF-5F1522583CA2

Q36396727-312CC7E0-B6C2-48E5-896C-915E4539590F

Q36396727-3A7ACB89-906F-44B2-98A8-6DD529006A3E

Q36396727-71AB5DBC-8E34-457A-8FDB-E9141B12236C

Q36396727-84BAB30F-11A8-4880-AC36-62013708F3CC

P2860

Q36396727-1A20D339-6920-4F5B-9FA9-E3B9C9F5C4FC

Q36396727-1A408C86-4901-4FBC-9BC1-FDB72B098D8E

Q36396727-1ADF33F3-FD3F-49AA-AEFE-12193D4026B5

Q36396727-1BC4F96D-2522-474B-A7F6-9F26D95D2A78

Q36396727-1F439918-AFEA-4D53-AC60-7D6D05521581

Q36396727-2B976522-1B4A-4F46-8543-F4ED3F5D4DE6

Q36396727-2C9B7778-A005-45AA-B71D-1052C46EFEBF

Q36396727-2F68CA7D-2AEB-4580-8BA3-0A0FEA187684

Q36396727-34662C9E-70E9-455A-8E03-0ED8DE653051

Q36396727-3E48C4AF-C71E-4E9F-A4BD-016AD0D0419C

P2888

Q36396727-34075D18-AB02-43DE-B451-346947D5950D

P304

Q36396727-E97242FB-E97A-4EE6-8754-D72BC15056CB

P31

Q36396727-42A349DF-0ECA-48CC-B46B-E479E55955F0

P356

Q36396727-5546EA87-DAFE-48E5-AB00-4D749A38BA94

P433

Q36396727-80333E79-5344-4970-A2DC-0EA732D0D537

P478

Q36396727-8B45134E-13B5-4F4B-A44C-BD8C91CBCFC7

P50

Q36396727-14C1A158-4557-4F14-8897-F5F73C60EE5F

Q36396727-28D3FC2D-601B-4ABD-85C4-A359C54966D7

P577

Q36396727-837F3F18-B5EC-4F3B-9EE3-3FA679E74291

P5875

Q36396727-3AD70A57-BC23-4BBC-BF13-5C3BED83095D

P698

Q36396727-5EA758D3-B6AB-4AED-94EB-958E4560152E

P356

SJ.EJHG.5201584

P1433

European Journal of Human Genetics

P1476

Phenotypic and genotypic heter ...... e and management implications.

@en

P2093

C Richard Boland

http://www.w3.org/2001/XMLSchema#string

Gordon Gong

http://www.w3.org/2001/XMLSchema#string

Henry T Lynch

http://www.w3.org/2001/XMLSchema#string

Jane F Lynch

http://www.w3.org/2001/XMLSchema#string

Patrick M Lynch

http://www.w3.org/2001/XMLSchema#string

Trudy G Shaw

http://www.w3.org/2001/XMLSchema#string

P2860

Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X

Genetic mapping of a locus predisposing to human colorectal cancer

Microsatellite instability in cancer of the proximal colon

Microsatellite instability in a pleomorphic rhabdomyosarcoma in a patient with hereditary non-polyposis colorectal cancer.

Genetic linkage analysis in hereditary non-polyposis colon cancer syndrome.

Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.

Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer.

P2888

sj.ejhg.5201584

P304

390-402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.EJHG.5201584

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Albert de la Chapelle

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7298285

http://www.w3.org/2001/XMLSchema#string

P698

16479259

http://www.w3.org/2001/XMLSchema#string